EMA — authorised 16 February 2017
- Marketing authorisation holder: Roche Registration Limited
- Status: approved
🇪🇺 Alecensa in European Union
EMA authorised Alecensa on 16 February 2017
Marketing authorisation
Alecensa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Alecensa approved in European Union?
Yes. EMA authorised it on 16 February 2017.
Who is the marketing authorisation holder for Alecensa in European Union?
Roche Registration Limited holds the EU marketing authorisation.